⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Investors to Inquire about Securities Investigation
accessnewswire.com
VALN
PFE
XtalPi Holdings Announces Full Year 2025 Annual Results USA - English APAC - Traditional Chinese
prnewswire.com
PFE
JKS
Peptide Therapeutics Market Growing at 7.16% CAGR to Reach USD 70.20 Bn by 2031 Driven by Rising Cancer Prevalence & Metabolic Disorder Burden, Reports Mordor Intelligence
prnewswire.com
PFE
ABBV
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
globenewswire.com
VALN
PFE
Incubate and the National Security Commission on Emerging Biotechnology Convene Capitol Hill Roundtable on U.S. Biotech Competitiveness
globenewswire.com
PFE
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
accessnewswire.com
LEXX
LLY
NVO
PFE
Robert Hollingsworth has been appointed as the Chief Scientific Officer of Protillion Biosciences
prnewswire.com
PFE
ILMN
Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis
globenewswire.com
PFE
GSK
TKO
Serina Therapeutics to Present at the 38th Annual Roth Conference
globenewswire.com
SER
PFE
Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis
globenewswire.com
PFE
TKO
GSK